4 terminated. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 4 |
| Phase 2 | 1 | Terminated 1 |
Follow Hematological Malignancy: new trials by email Literature Review of Hematological Malignancy trials Research Report on Hematological Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma. SG2501 - Hematological Malignancy, Lymphoma | Phase 1 | Terminated | Hangzhou Sumgen Biotech Co., Ltd. | 2 | 2023-03-03 | 2025-03-18 |
| Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies ATG-017, ATG-017+Nivolumab - Solid Tumor, Hematological Malignancy | Phase 1 | Terminated | Antengene Therapeutics Limited | 36 | 2020-08-15 | 2024-07-23 |
| Body Scan Activity on Bone Marrow Transplant Patients and Their Caregivers Body Scan, Rotterdam Symptom Checklist, Practice Logs - Hematological Malignancy | Phase 1 | Terminated | Washington University School of Medicine | 37 | 2018-04-17 | 2018-10-31 |
| Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL MT-3724 Phase 1, MT-3724 Phase 2 - Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1 / Phase 2 | Terminated | Molecular Templates, Inc. | 38 | 2015-02-01 | 2022-08-18 |
Hematologic Neoplasms (4) · Lymphoma (2) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, B-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Non-Hodgkin (1) · Neoplasms (1) · Recurrence (1)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Neoplasms by Site (4) · Neoplasms (3) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms by Histologic Type (2) · Chronic Disease (1) · Disease Attributes (1) · Leukemia, B-Cell (1) · Leukemia, Lymphoid (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Antibodies, Bispecific (1) · Whole Body Imaging (1)
Antengene Therapeutics Limited (1) · Hangzhou Sumgen Biotech Co., Ltd. (1) · Molecular Templates, Inc. (1) · Washington University School of Medicine (1)
United States (3) · Australia (1) · Belarus (1) · Canada (1) · Georgia (1) · Israel (1) · Moldova (1) · Poland (1) · Serbia (1) · Spain (1) · Ukraine (1)
Anupa Kudva, MD (1) · Maggie Compernolle, BSN, RN (1) · Sai Lou, MD (1) · Yiqiang Zhao, MD (1)